HS-10516 + Lenvatinib

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Advanced Clear Cell Renal Cell Carcinoma

Drug Information

Target Indication

Advanced Clear Cell Renal Cell Carcinoma

Clinical Trial

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

HNSPF

Hansoh Pharmaceutical Group Co Limited/ADR

Related Pipeline

Small Cell Lung Cancer

Non-small Cell Lung Cancer

Advanced Solid Tumor

Ovarian Cancer

CML, CML-CP,MMR,TKI